{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33323384",
  "DateCompleted": {
    "Year": "2020",
    "Month": "12",
    "Day": "31"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "02",
    "Day": "04"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "12",
        "Day": "15"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1136/bmj.m4735"
    ],
    "Journal": {
      "ISSN": "1756-1833",
      "JournalIssue": {
        "Volume": "371",
        "PubDate": {
          "Year": "2020",
          "Month": "Dec",
          "Day": "15"
        }
      },
      "Title": "BMJ (Clinical research ed.)",
      "ISOAbbreviation": "BMJ"
    },
    "ArticleTitle": "Equitable global access to coronavirus disease 2019 vaccines.",
    "Pagination": {
      "StartPage": "m4735",
      "MedlinePgn": "m4735"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Health Policy and Management, Yale School of Public Health, New Haven, CT 06510, USA."
          }
        ],
        "LastName": "Schwartz",
        "ForeName": "Jason L",
        "Initials": "JL"
      }
    ],
    "PublicationTypeList": [
      "Editorial"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "BMJ",
    "NlmUniqueID": "8900488",
    "ISSNLinking": "0959-8138"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "BMJ. 2021 Feb 2;372:n302",
      "PMID": "33531343"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "prevention & control",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Global Health"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Health Services Accessibility"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "organization & administration"
      ],
      "DescriptorName": "Immunization Programs"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Vaccination Coverage"
    }
  ],
  "CoiStatement": "Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The author declares the following other interests: None. The BMJ policy on financial interests is here: https://www.bmj.com/sites/default/files/attachments/resources/2016/03/16-current-bmj-education-coi-form.pdf."
}